Expression of hypothalamic hormone receptors in pituitary adenomas
Expression of hypothalamic hormone receptors in pituitary adenomas
批准号:
14571342
负责人:
OYAMA Ken-ichi
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The hormonal secretion of the pituitary gland is controlled by the inhibitory factor or the stimulating factor from the hypothalamus. To date, expression of several hypothalamic hormones and receptors in the pituitary gland have been reported, and their role for tumorigenesis, cell differentiation and cell growth are suggestied. In this study, we investigated the expression of various hypothalamus hormone receptors and transcription factors in human normal pituitaries and different types of human pituitary adenomas using the RT-PCR and immunohistochemical techniques, and aimed to clarify their contribution to tumorigenesis, cell differentiation and cell growth. Concerning about transcription factors, we examined PTX-1,Neuro D1,Pit-1 and Estrogen receptor(ER). PTX-1 and Neuro D1 were expressed in all types of pituitary adenomas. Pit-1 was especially expressed in GH secreting, PRL secreting and TSH secreting adenomas, and also expressed in some non-functioning adenomas, that indicate Pit-1 may be influenced by a-subunit. ER was expressed in PRL secreting and gonadal hormone secreting adenomas, that indicate ER has interaction with Pit-1. Concerning about hypothalamic hormones and their receptors, we studied the expression of GHS-R and TRH-R. Their strong expressions in all GH secreting adenomas were showed by RT-PCR study and immunohistochemical study including in situ hybridization method. We also investigated the expression of Ghrelin, strong endogenious ligands for GHS-R, in pituitary adenomas, there exist no correlation between them. Our result suggest that transcription factors have interaction with hypothalamic hormones and its receptors, and they have some contributions to tumorigenesis, cell differentiation and cell growth of pituitary adenomas.
期刊论文(78)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sanno N, Osamura RY, Teramoto A, et al.: "Pathology of Pituitary Tumors"Neurosurgery Clinics of North America. 14・1(In press). (2003)
Sanno N、Osamura RY、Teramoto A 等:“垂体肿瘤的病理学”北美神经外科诊所 14・1(印刷中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Pituitary adenoma with "Honeycomb golgi appearance showing a phenotypic change at recurrence from clinically nonfunctioning to typical Cushing disease
垂体腺瘤具有“蜂窝状高尔基体外观,在复发时表现出从临床无功能到典型库欣病的表型变化”
DOI:
--
发表时间:
2002
期刊:
Endocrine Pathology 53(2)
影响因子:
--
作者:
[Sano T, Kovacs K, Asa SL, Yamada S, Sanno N, et al.]
通讯作者:
et al.
診断が困難であったトルコ鞍部に生じた稀なneuroblastomaの一例
一例罕见的蝶鞍神经母细胞瘤,难以诊断。
DOI:
--
发表时间:
2004
期刊:
ホルモンと臨床 vol25
影响因子:
--
作者:
[大山健一, 山田正三, 山下安佐美, 金景成, 臼井雅昭, 小澤安則]
通讯作者:
小澤安則
Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the a subunit of G protein.
人产生 GH 的垂体腺瘤中的 Ghrelin mRNA 和 GH 促分泌素受体 mRNA 受到 G 蛋白 a 亚基突变的影响。
DOI:
--
发表时间:
2003
期刊:
Clin Endocinol 59
影响因子:
--
作者:
[Kim K, Sanno N, Arai K, et al.]
通讯作者:
et al.
山王直子, 田原重志, 寺本 明: "エビデンスに基づく神経精神疾患の治療戦略-プロラクチノーマ"脳の科学. 25. 919-923 (2003)
Naoko Sanno、Shigeshi Tahara、Akira Teramoto:“神经精神疾病的循证治疗策略 - 泌乳素瘤”《脑科学》25. 919-923 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 31 条
海外基金